Researchers have shed new light on the most common genetic variant linked to hereditary cancer in Quebec's French-Canadian ...

Sickle cell disease can lead to a severe complication known as acute chest syndrome (ACS), but the underlying mechanisms are not well understood.

Intranasal fentanyl is a feasible, safe, and effective option for managing acute pain episodes in adults with sickle cell ...

Want a bespoke baby? Check the beauty, brains, or brawn boxes on the embryo order form. Genetic tinkering is no longer science fiction—it’s a market without legal guidelines or societal buy-in. But ...

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

According to Coherent Market Insights (CMI), the global sickle cell disease treatment market size is expected to expand from USD 3.20 Bn in 2025 to USD 8.81 Bn by 2032, recording a CAGR of 15.6% ...

SRT CEO Patrick Girondi and Artist and Project Manager Megan Euker with newly restored San Rocco sculpture, Altamura, Italy.

The Centers for Medicare and Medicaid Services has named 33 states, as well as Washington, D.C., and Puerto Rico, as participants in its Cell and Gene Therapy Access Model, which is designed to treat ...

CMS is brokering outcomes-based agreements on behalf of Medicaid programs. Thirty-three states, along with Washington, D.C., ...

The participating regions are home to 84 percent of sickle cell Medicaid patients who could gain access to gene therapies under outcomes-based agreements.

CMS has reached agreements with drug manufacturers to provide gene therapies to treat sickle cell disease to Medicaid recipients under a new outcomes-based model. A total of 33 states, including the ...

States representing about 84% of Medicaid beneficiaries are participating in an initiative that enables the U.S. government ...